EchoGo® Heart Failure vs iCAC Device
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 60/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A focuses on diagnosing Heart Failure with preserved Ejection Fraction (HFpEF) by analyzing echocardiograms, providing rapid insights for clinical decisions. In contrast, Tool B analyzes routine chest CT scans to detect and quantify coronary artery calcium (CAC), aiding in the early identification of cardiovascular disease risk. While both are cardiology AI tools, they address different clinical questions and utilize distinct imaging modalities, making them complementary rather than direct competitors.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
EchoGou00ae Heart Failure is an AI platform that analyzes routine echocardiograms to detect Heart Failure with preserved Ejection Fraction (HFpEF). The iCAC Device is an AI algorithm that detects and quantifies coronary artery calcium (CAC) from routine chest CT scans, aiding in early cardiovascular disease detection.
EchoGou00ae Heart Failure analyzes routine echocardiograms, specifically routine echo video clips. The iCAC Device analyzes routine, non-contrast, non-gated chest CT scans.
EchoGou00ae Heart Failure delivers insights within 20 minutes and provides automated structured reports, with clinically validated performance of 90% sensitivity and 86% specificity for HFpEF. The iCAC Device provides adjunctive information to radiologists, including a visual representation of estimated CAC segmentation and exact and four-category quantitative estimates of CAC burden in Agatston units.
EchoGou00ae Heart Failure offers seamless integration with existing workflows and IT stacks, utilizing a DICOM workflow for report delivery to PACS. The iCAC Device integrates with PACS or a DICOM router and can integrate with EHRs via the Carebricks platform.
EchoGou00ae Heart Failure is reimbursable via CPT code 0932T for outpatient analysis, with a national Medicare average of $316 per analysis, and is covered by Medicare and select commercial insurers. For the iCAC Device, pricing details are not available, and users are advised to contact the vendor for pricing information.
Both EchoGou00ae Heart Failure and the iCAC Device are FDA-cleared. EchoGou00ae Heart Failure is clinically validated with 90% sensitivity and 86% specificity for HFpEF. The iCAC Device's performance was validated in a retrospective study, demonstrating an overall alignment rate of 79.7% and calcium-score-group level positive predictive values of 68.1% to 90.1% compared to ground truth.
EchoGou00ae Heart Failure is relevant for Cardiology, Emergency Medicine, and Internal Medicine. The iCAC Device is primarily for Cardiology and Radiology specialties.